Rationale: Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory
tract infections and hospitalizations in infants worldwide. Known risk factors, however, …

Severe disease of SARS-CoV-2 is characterized by vigorous inflammatory responses in the
lung, often with a sudden onset after 5–7 days of stable disease. Efforts to modulate this …

Background. Oseltamivir provides modest clinical benefits to children with influenza when
started within 48 hours of symptom onset. The effectiveness of oseltamivir could be …

Background Viral infections may trigger type 1 diabetes (T1D), and recent reports suggest an
increased incidence of paediatric T1D and/or diabetic ketoacidosis (DKA) during the COVID…

Severe COVID-19 is characterized by extensive pulmonary complications, to which host
immune responses are believed to play a role. As the major arm of innate immunity, neutrophils …

Rationale: Rhinoviruses (RVs) are a major cause of symptomatic respiratory tract infection
in all age groups. However, RVs can frequently be detected in asymptomatic individuals. …

Background Few prospectively collected data are available to support the effectiveness of
inactivated influenza vaccines in children younger than 2 years. We aimed to establish the …

Respiratory viral infections represent the leading cause of hospitalization in infants and
young children worldwide, and the second cause of infant mortality. 1 Of all Disclosures: A. …

Mycoplasma pneumoniae is a common cause of respiratory tract infections with community-acquired
pneumonia as the major disease-related burden. Compared with other pathogens, …

Background Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory
condition associated with SARS-CoV-2 infection, has emerged as a serious illness in children …